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Abstract
Alternative drug combinations are anesthetically equipotent but have different re-emergence and
nociception outcomes. The perfect drug combination - causing a short post surgery wake up time
and an extended time until pain - is dependent on the patient, surgical stimulus, and previous
dosing. Our goal is to create a technique to find optimized drug dosings that lessens re-emergence
time and extends nociception. Method - Use records from 20 general anesthestic procedures that
involved Remifentanil and Propofol we calculated equipotent concentrations with more desireable results. Results - The optimization technique improved post surgery re-emergence time on
average 5.22 minutes and lengthened nociception time on average 4.22, 7.55, and 9.84 minutes for
the three different cases. Discussion - This technique fulfills its primary goal to find more optimal concentrations for anesthesia. The technique is capable of clinical practice to offer optimal
suggestions to the anesthesiologist during surgery.

Introduction
In anesthesia multiple drugs are used to ensure a patient’s well being during the surgical procedure. Uncertainty arises from the drug to drug interactions reacting additively, antagonistically, or
synergistically; this interaction is pharmacokinetic variability. By accounting for patients’ individual physical characteristics and drug concentrations models predict the synergistic interactions
and expected response to a stimulus. However, another uncertainty also exists from individual
pharmacodynamic variability, which is caused by unknown reactions in the body to the drugs.
Due to the elusiveness of the pharmacokinetic and pharmacodynamic variability it is difficult
for the anesthesiologist to know how individual patients will react or emerge from an anesthetic
experience. The anesthesiologist can only perceive the responsive cues from the patient during
the surgery: pulse rate, blood pressure, and muscle activity. Alleviating part of pharmacokinetic
variability during anesthesia will potentiate optimization of the anesthetic experience; especially
within the range of our focus to both minimize the sedation effect and maximize the analgesic
effect at the end of surgery. By tracking drug administration during surgery, we can estimate the
future recovery and nociception time and recommend alternate equipotent concentrations with
quicker recovery times and extended nociception times. This will be used by anesthesiologist
during surgery to provide optimal drug cocktails with surgery and patient specificity.
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Method
The 3 compartment pharmacokinetic drug model has been widely accepted to describe the biodistribution of drugs. The rate constants for the drug model have been found through laborious
testing. The rate constants that we use are from Schnider for Propofol and Minto and Schnider for
Remifentanil.1,2

Figure 1: General form of the classic 4 compartment drug model
Vuyk et al. noticed the synergistic effect of drug to drug interactions; when using two drugs
they found that various drug concentrations have different wake up times.3 Consequently the
quickest wake up time was found for each of the four different scenarios surgeries. Vuyk’s trial and
error methods were extensive; however their findings introduced the concept of using synergistic
drug interactions to decrease re-emergence time after surgery.
Kern et al. created population models of the synergistic behavior between propofol, a sedation
drug, and remifentanil, an analgesic opiate4 . Assuming these models correctly depict patients
anesthetic orientation we can quantify an expectation for the patient’s response due to given stimuli. Later Manyam showed similar synergistic results when remifentanil was combined with an
inhaled agent, sevoflourane.5
The data used was from a library of anesthetic cases. A technician was present for each of the
20 surgeries recording the patients physical characteristics, doses administered, and the surgical
events. Each surgery included general anesthesia; there were no specifications on the surgical
procedure or the equpiment used by the anesthesiologist. For the surgery the anesthesiologist
was only allowed to use remifentanil, fentanyl, and propofol as the anesthetic agents. The three
drugs chosen for this optimization technique - remifentanil, fentanyl, and propofol - were chosen
for their individual differences and highly synergistic effects. Remifentanil and fentanyl are very
similar in their analgesic effects, but vary drastically in their half life times. These two analgesic
drugs can be combined into an overall remifentanil effect3 although for simplicity the initial optimization will ignore the fentanyl administration, only accounting the propofol and remifentanil
administrations.
A patient’s depth of anesthesia is difficult to pinpoint; however, response surface models classify levels of anesthesia and will be utilized to quantify otherwise abstract levels of consciousness
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and nociception. With response surfaces an expected response to a given stimuli corresponds to
an array of drug pair concentrations. The desired reactions that need quantification are the anesthesia level, the re-emergence time, and the nociception time. We assume the level of anesthesia
corresponds to the expected response to laryngoscopy response surface (lar). We also assume the
average patient feels pain at the 25 % isobole on the electrical tetany response surface (tet) this will
be called the nociception time or the time until pain. To quantify re-emergence time we use the
observation alert assesment/sedation OAA/S < 2 response surface (oa2) to be referred to as the
re-emergence time or the wake up time. Specifically for each surgery we find the point in time
on the expected response to OAA/S< 2 when they woke up, this value then becomes the patients
wake up point on the OAA/S < 2 surface. Thus, by using the response surfaces mentioned earlier
from Kern et al. we calculate the expected response to larnygoscopy, OAA/S < 2, and electrical
tetany. An example of these levels of probability to a given stimuli is shown later in fig. 4.
The response surface models are found using the equation from Kern et al.3 . The values used
are new values that were obtained from a more recent unpublished study by Kern et al.
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Table 1: Response surface parameters
My solution to the pharmacokinetic model
The pharmacokinetic model includes 3 or 4 main compartments with rate constants describing the
rate of drug transfer between compartments. The model is a simple linear system of differential
equations. Infusing the drug creates a continuous piece-wise function that is not easily differentiable. Thus most solutions to this model are done with computer based iterative approximations.
To solve this problem we have formulated and new 5 compartment model, adding a compartment
for the effect site and the infusion. The pharmacokinetic model seen in figure 1, describes the kinetics of a drug throughout the body. Drugs are first introduced to the blood system via intravenous
administration. The rate constant from the infusion compartment to the blood is governed by the
infusion itself. The infusion rate constant is held constant by making the infusion compartment of
near infinite size. The drug circulates in the blood till it is absorbed by the tissues. Various tissues
absorb the drug quickly while other tissues saturate at a slower rate. An effect site only directly
linked to the blood volume is the place of drug efficacy. This new five compartment drug model
creates a linear system of differential equations of the drug bio-distribution throughout the body.
From the model the characteristic differential equations are. . .
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Figure 2: 5 compartment drug model

dA1
dt
dA2
dt
dA3
dt
dA4
dt
dA5
dt

= (−k12 − k13 − k14 − k10 )A1 + k21 A2 + k31 A3 + k41 A4 + kI A5

(1)

= k12 A1 − k21 A2

(2)

= k13 A1 − k31 A3

(3)

= k14 A1 − k41 A4

(4)

= −k51 A5

(5)

Which can also be written in the form
dA
= [M ]A
dt
Let v = the matrix of eigen vectors of M
Let p = [v]−1 A
Then for i = 1, . . . , 5
Ai = p1 eλ1 t vi,1 + p2 eλ2 t vi,2 + p3 eλ3 t vi,3 + p4 eλ4 t vi,4 + p5 eλ5 t vi,5
A is the amount of drug in the specific compartment. K is the corresponding rate constant
between compartments, which are notably different for each drug.
With the analytical solution we first need to understand visually the difference between the
pharmacokinetics of the drugs. Each drug has different kinetics, as shown in fig. 12, and must be
tracked individually.
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(a) Propofol infusion

(b) Remifentanil infusion

Figure 3: Examples of bio-dispersion of Remifentanil and Propofol after infusions. Shown to compare the differences in half life between Remifentanil and Propofol. Infusion duration was the
same for both simulations starting with initial concentrations of 0 in all the compartments.
Surgery Number
Weight
Height
Age
Sex

15
93.4 (kg)
180 (cm)
20 (years)
Male

Table 2: Patient # 15 characteristics
As an example of the optimization technique for patient # 15 from the study will be shown,
this patient was chosen randomly. The patient’s individual characteristics are represented in tab.
2. The drug administration from the anesthesiologist is shown in fig. 2
According to this patient’s characteristics and the drug administration that they received we
find the concentrations for each drug in each compartment. The effect site concentrations are
shown in fig. 3. The population expectation to surgical events is calculated for the patient according to their drug administration as seen in fig. 4.
Next we want to optimize the surgery. The optimization can not allow the patient to fall below
the current anesthetic level and sedation level, this is assuming that the anesthesiologist knew
the required level of anesthesia for the patient. We need to choose the best concentrations that
produce at least the same expected response. Thus the canonization is set by the re-emergence
and anesthetic level curves and is represented by the fig. . The concentrations can not fall below
either curve, thus the possible optimal points are the red curve to the left and the blue curve to
the right of the current dose. Each possible optimal point has a different wake up and nociception
profile. To find this profile we use a TCI technique to reach the intended concentration then the
infusions are shut off and the drugs eliminate from the body. Using the resopnse surface models
and the previous assumptions on re-emergence and nociception we achieve the profile times for
that concentration. This is repeated for each possible concentration keeping the TCI duration
constant for each one; TCI reached the target after a minute or two, but the duration constant was
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Figure 4: Administered Infusions
set for 5 minutes to allow adequate time for quasi-equilibration. The profile times are shown for
the example case in fig. . The concentration pairs are referred to as a concentration index for easier
bookkeeping where each change in concentration index corresponds to a .1 change in propofol
concentration. The re-emergence time is measured by the difference in time between the end of
surgery (all infusions turned off) and the expected re-emergence point. The nociception time is
the difference in time between the re-emergence time until the time the patient is expected to feel
pain.
What concentration index corresponds to the best outcome? This depends on the preference
of the anesthesiologist. If the goal is to minimize post surgery wake up time then the best concentration will be at the minimum of the re-emergence curve. However, if a minute can be spared
on the expected post surgery wake up time then the expected time until pain increases by about
4 minutes, in this example. There is no distinct answer to this balance situation, other than; How
much does the anesthesiologist value analgesia at the expense of post-surgery re-emergence?
A linear combination of the two profile times with multipliers allows for easy change of priority. The weighting function designed to minimize re-emergence time and maximize nociception
time is
f = A(re-emergence time) − B(nociception time)
The multipliers indicate the anesthesiologist priority a high A indicates a strong inclination to
wake the patient shortly after surgery to a low A indicates the anesthesiologist doesn’t care how
long it takes them to wake up as long as they don’t feel any pain. The multipliers role is seen in
the fig. 7. They multipliers can be any real number but are normalized to one.
The example was shown for one point in time. If this technique is repeated every five minutes,
then a more optimized set of dosing can be compared to the original administered dosing. For the
example run the optimized doses are shown compared to the original dosing from the anesthesiologist in fig. 8. These alternative doses produce an anesthetic effect at least as potent as the effect
from the original dosing.
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Figure 5: Original doses as administered by the anesthesiologist during surgery. Blue line indicates
the drug concentration in the effect site, the green line is the drug concentration in the plasma, the
red line is the drug concentration in the fast equilibrating tissues, and the black line is the drug
concentration in the slow equilibrating tissues.

Results
Our goal to minimize wake up time while providing adequate analgesia was successful. The
results depend on the weights used, but each optmization produced a decrease in the wake up
time by about 5 minutes on average and the nociception time was increased by 4 to 10 minutes,
as is shown in fig. . This allows for a general improvement and flexibility depending upon the
specific surgical case. The optimized cases are all closer to the more optimal part of the figure
shown. Also notice that the optimization technique limited the expected deviation presented by
the decrease in length the bars of the same figure.
To illustrate the differences between the optimized dosing and the original dosing the end
concentrations are plotted in fig. ??. These differences are the last optimization right before the
end of surgery. The results from the weights a=.25 b=.75 and a=0 b=1 are nearly equivalent to the
results from the weigths a=.5 b=.5 and thus are not shown in the figure.

Conclusion
This optimization technique showed improvement for ”typical” cases and has the capability to
vastly optimize longer or complex surgeries. This technique analyzed Remifentanil and Propofol
use which are fast acting drugs more drastic results are expected if slower acting drugs were used.
This optimization technique will be able to help the anesthesiologist achieve a better understanding of the anesthetic orientation of the patient, which will help avoid overdosing and under dosing
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Figure 6: Expected responses to stimuli from the original administered doseses in surgery case 15
and their associated complications.
Re-emergence time and nociception time are dependent. There is no absolute best concentration of drugs to use for the best re-emergence and nociception times, however they are always
changing due to the patients, demographics of the surgery, and previous drug administrations
and will keep changing as the surgery itself continues.
How useful is this recommended dose for the anesthesiologist? Due to the fact of the pharmacodynamic variability this technique is not exact for the individual patient, but is based on a
population of patients. The surface models predict the expected response to stimuli which correlate with re-emergence time and time until nociception returns. These values are approximations
and not exact; however they do find concentrations with more optimal elimination profiles from
the body. Future research is looking for ways to adapt the response surfaces with individual patient specificity to eliminate more of the pharmacodynamic variability.
The best application of this will be with longer surgeries that last many hours when the slower
equilibrating drugs have had time to fully saturate all the compartments in the body. The longer
the slow equilibrating compartment has to fill then the longer it will take that compartment to
empty. It is emptied through the blood or the main compartment and prolongs the anesthetic
effect, of sedation, long after the infusion is attenuated.
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Figure 7: Ending possibilities, isoboles for given stimuli with same expected response, the possible
drug combinations can not fall below either of the curves. The current dose indication is the one
point on the curve.

Figure 8: Expected re-emergence and nociception times for the possible concentrations. The current dose indication is the one point on the curve. Note here that the current dose is almost the
minimum of the re-emergence profile curve, choosing a point to the left of the current dose will
increase nociception time while keeping re-emergence time close to the current value.
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Figure 9: Weight function, the minimal point is indicated with the black dot. This shows the
difference of weighting possibilities depending on how important the anesthesiologist deems reemergence or nociception time.

Figure 10: original doses vs optimized doses
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Figure 11: Nociception time plotted against the re-emergence time. Cirlces indicate the average
time and the bars indicate the standard deviation.
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Figure 12: The three different weights. Top left figure A = 1, B = 0; Top right figure A = .75, B = .25;
Bottom figure A = .5, B = .5
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